| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Avadel Pharmaceuticals Plc (AVDL) has 6 insiders with recent SEC Form 4 filings, including 12 buys and 0 sells. AVDL is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 115.1K | - | - | |
| Dir | 22.0K | - | - | |
| Dir | 22.0K | - | - | |
| Dir | 11.0K | - | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2016 | Stapleton Craig R | Director | Buy | 10,000 | $13.52 | $135,190.00 | +2.0% | |
| Aug 26, 2016 | Stapleton Craig R | Director | Buy | 20,000 | $13.76 | $275,140.48 | +183.9% | |
| Aug 22, 2016 | Anderson Michael S | Chief Executive Officer | Buy | 5,000 | $14.30 | $71,478.50 | +2.7% | |
| May 16, 2016 | Stapleton Craig R | Director | Buy | 27,228 | $9.21 | $250,891.29 | +2.8% | |
| May 12, 2016 | Anderson Michael S | Chief Executive Officer | Buy | 5,000 | $8.84 | $44,200.00 | +3.9% | |
| Mar 22, 2016 | Thompson Phillandas T. | See Remarks | Buy | 10,000 | $11.10 | $111,030.00 | +100.0% | |
| Mar 18, 2016 | Anderson Michael S | Chief Executive Officer | Buy | 5,000 | $11.04 | $55,220.00 | +4.0% | |
| Mar 18, 2016 | Hatten Sandra L | Sr. VP, Quality &Reg Affairs | Buy | 3,000 | $11.01 | $33,030.00 | New | |
| Mar 14, 2016 | Anderson Michael S | Chief Executive Office | Buy | 10,000 | $9.74 | $97,350.00 | +8.8% | |
| Mar 14, 2016 | Stapleton Craig R | Director | Buy | 100,000 | $10.39 | $1,039,400.00 | +26.1% |